E-Mail karger@karger.com Interventional Pulmonology Respiration 2014;88:244–250 DOI: 10.1159/000363063 Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration: Patient Satisfaction under Light Conscious Sedation Abiramy Jeyabalan Andrew R.L. Medford North Bristol Lung Centre, North Bristol NHS Trust, Southmead Hospital, Bristol, UK midazolam. The sensitivity of EBUS-TBNA for the cancer stag- ing, cancer diagnosis and granulomatous disease cohorts was 90.0, 94.1 and 87.5%, respectively. The most commonly reported symptom was a cough in 65 (93%) patients. Of these patients, 46 (71%) described the severity as being mild. All but 9 patients (61/70 or 87%) stated that they would def- initely or probably undergo a repeat EBUS-TBNA. Conclu- sions: This single-centre UK study confirms that EBUS-TBNA under light conscious sedation is a well-tolerated procedure maintaining the expected diagnostic performance, with pa- tients reporting a high degree of satisfaction with both the test and the information received beforehand. © 2014 S. Karger AG, Basel Background Endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) is a mediastinal sam- pling technique recommended by the National Institute of Clinical Excellence [1] for the staging and diagnosis of non-small-cell lung cancer. It is also used to diagnose un- explained accessible mediastinal adenopathy and lesions [2]. The procedure can be carried out under general an- aesthesia with the use of airway adjuncts but is common- ly performed under light conscious sedation in UK cen- tres in an endoscopy room with a short-recovery area. Key Words Patient satisfaction · Endobronchial ultrasound · Transbronchial needle aspiration · Conscious sedation Abstract Background: Endobronchial ultrasound-guided transbron- chial needle aspiration (EBUS-TBNA) is an increasingly used mediastinal sampling technique. Many centres use con- scious sedation in an ambulatory setting to optimise the flow of patients, save costs and shorten recovery time. The only EBUS-TBNA patient satisfaction study published so far used deep conscious sedation with propofol. To our knowl- edge, ours is the largest prospective study evaluating the experience of patients undergoing EBUS-TBNA using light conscious sedation without propofol. Objectives: To evalu- ate the patient tolerability of EBUS-TBNA under mild con- scious sedation. Methods: Eighty-two consecutive patients between January 2011 and November 2011 requiring EBUS- TBNA under light conscious sedation for either mediastinal staging of lung cancer or the diagnosis of suspected medi- astinal disease due to malignancy or granulomatous disease were invited to complete a questionnaire after the interven- tion. The collection of data included the diagnostic yield, the number and size of nodes sampled and the dose of sedative medication administered. Results: The average dose of sed- ative agents administered was 59.4 μg fentanyl and 3.2 mg Received: October 7, 2013 Accepted after revision: April 22, 2014 Published online: August 21, 2014 Dr. Andrew R.L. Medford North Bristol Lung Centre and University of Bristol Southmead Hospital, Westbury-on-Trym Bristol BS10 5NB (UK) E-Mail andrewmedford  @  hotmail.com © 2014 S. Karger AG, Basel 0025–7931/14/0883–0244$39.50/0 www.karger.com/res Downloaded by: A. Medford - 145382 Frenchay Hospital 82.33.242.34 - 9/3/2014 6:41:38 PM